Open AccessRole of dipeptidyl peptidase 4 inhibitors in the new era of antidiabetic treatment
Author(s) -
Matilda Florentin,
Michael S. Kostapanos,
Athanasia Papazafiropoulou
Publication year - 2022
Publication title -
world journal of diabetes
Language(s) - English
Resource type - Journals
ISSN - 1948-9358
DOI - 10.4239/wjd.v13.i2.85
Subject(s) - medicine , diabetes mellitus , dipeptidyl peptidase 4 , hypoglycemia , glycemic , context (archaeology) , adverse effect , diabetes management , pharmacology , drug class , type 2 diabetes , glucagon like peptide 1 , glucose homeostasis , drug , dipeptidyl peptidase , endocrinology , insulin resistance , paleontology , biochemistry , chemistry , enzyme , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom